Combined Hesperidin and Doxorubicin Treatment Induces Apoptosis and Modulates Inflammatory Cytokines in HeLa Cervical Cancer Cells
International Journal of Molecular Sciences · 08.09.2025 · 26 (17) · 8753
DOI: 10.3390/ijms26178753 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.09.2025. Verfasst von İlhan Özdemir und 3 weiteren Autor:innen. Beteiligte Einrichtung: IVF Center, Private Buhara Hospital, Erzurum 25070, Turkey. Hauptthemen laut MEDLINE: Hesperidin, Apoptosis, Doxorubicin, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cervical cancer is a major gynecological malignancy linked to hormonal dysregulation and genetic alterations. Chemotherapy is standard but limited by toxicity and chemoresistance, prompting interest in plant-derived adjuncts. This study examined the anticancer and immunomodulatory effects of Hesperidin (Hes), a citrus flavonoid, with Doxorubicin (DX) in HeLa cervical cancer cells. Cell viability was assessed by MTT assay, apoptotic markers (Bcl-2, Caspase-3) by RT-qPCR, and inflammatory cytokines (IL-1β, IL-6, TNF-α, IFN-γ) by ELISA. Cytokine levels were normalized to 104 viable cells, and mRNA expression of all four cytokines was quantified by RT-qPCR, confirming protein-level changes and showing the strongest IL-6 suppression with Hes+DX. Chou–Talalay combination index (CI) analysis demonstrated synergistic interactions (CI < 1.0) between Hes and DX across all tested concentrations, with strong synergism (CI < 0.7) at medium and high doses, particularly at 48 and 72 h. Hes alone showed dose-dependent cytotoxicity, while the combination markedly increased Caspase-3, reduced Bcl-2, and decreased IL-1β, IL-6, and TNF-α, indicating enhanced intrinsic apoptosis and complementary immunomodulation. These results suggest that Hes augments DX’s pro-apoptotic and anti-inflammatory effects, potentially allowing lower chemotherapy doses and reduced systemic toxicity in cervical cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IVF Center, Private Buhara Hospital, Erzurum 25070, Turkey.
- Gynecology and Obstetrics, Private Batman Life Hospital, Batman 72040, Turkey.
- Department of Anatomy, Faculty of Medicine, Dicle University, Diyarbakır 21200, Turkey.
- Vocational School of Health Services, Çanakkale Onsekiz Mart University, Çanakkale 17100, Turkey.
ORCID-Profile: Mehmet Cudi Tuncer
Zitieren
APA
Özdemir, İ., Afşin, Y., Tuncer, M. C., & Öztürk, Ş. (2025). Combined Hesperidin and Doxorubicin Treatment Induces Apoptosis and Modulates Inflammatory Cytokines in HeLa Cervical Cancer Cells. International Journal of Molecular Sciences, 26(17), 8753. https://doi.org/10.3390/ijms26178753
Vancouver
Özdemir İ, Afşin Y, Tuncer MC, Öztürk Ş. Combined Hesperidin and Doxorubicin Treatment Induces Apoptosis and Modulates Inflammatory Cytokines in HeLa Cervical Cancer Cells. International Journal of Molecular Sciences. 2025;26(17):8753. doi:10.3390/ijms26178753
BibTeX
@article{zdemir2025,
author = {Özdemir, İlhan and Afşin, Yasemin and Tuncer, Mehmet Cudi and Öztürk, Şamil},
title = {Combined Hesperidin and Doxorubicin Treatment Induces Apoptosis and Modulates Inflammatory Cytokines in HeLa Cervical Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {17},
pages = {8753},
doi = {10.3390/ijms26178753}
}
EUVIMED